The new material can be used to 3D print flexible, stable, three-dimensional structures at body temperature, which could accelerate medical research and drug discovery.
McMaster researchers, biopharmaceutical company Boehringer Ingelheim (Canada) Ltd. and St. Joseph’s Healthcare Hamilton have developed a kit that offers support and resources for people recently diagnosed with ILD.
A bioengineered lung model that can respond to viruses and drug treatments will advance our understanding of lung disease and biology, say researchers.
McMaster logo
McMaster logo
